Credit Agricole S A Halozyme Therapeutics, Inc. Transaction History
Credit Agricole S A
- $30.9 Billion
- Q1 2025
A detailed history of Credit Agricole S A transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Credit Agricole S A holds 38,855 shares of HALO stock, worth $2.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
38,855
Previous 11,056
251.44%
Holding current value
$2.04 Million
Previous $528,000
369.51%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HALO
# of Institutions
594Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$926 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$674 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$318 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$205 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$193 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.32B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...